[1]
Ronanki, K., Benson, R., Kacchwaha, A. and Nath, U.K. 2026. Melasma-like facial hyperpigmentation associated with long-term dasatinib therapy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: a rare cutaneous adverse event. International Journal of Basic & Clinical Pharmacology. 15, 5 (Aug. 2026), 1035–1038. DOI:https://doi.org/10.18203/2319-2003.ijbcp20262878.